So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

Medicare does not typically cover ketamine infusions for mental health conditions. However, it may cover Spravato, an FDA-approved drug deriving from ketamine, for treatment-resistant depression.

Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...

County Durham and Darlington Police and Crime Commissioner (PCC) Joy Allen has welcomed Government plans to seek advice on ...

The FDA approved Johnson & Johnson's Spravato, a ketamine-based nasal spray, to treat adults with major depressive disorder ...